The company fought off association with poor performing IPOs from the same sector, which continues to suffer from Chinas melamine scandal. Biostime instead emphasised its European production lines, its well known brand in China and its growth potential in the sector."The company really focused on its brand ...
Please take a trial or subscribe to access this content.
Contact Mark Goodes to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please call Mark Goodes on +44 (0)20 7779 8605 or email email@example.com to discuss your requirements.